Transfusion Medicine and Hemotherapy

Papers
(The TQCC of Transfusion Medicine and Hemotherapy is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies22
Challenges for Plasma-Derived Medicinal Products19
Safety of Intraoperative Cell Salvage in Cancer Surgery: An Updated Meta-Analysis of the Current Literature18
West Nile Virus in Germany: An Emerging Infection and Its Relevance for Transfusion Safety18
Low-Titer Group O Whole-Blood Resuscitation in the Prehospital Setting in Israel: Review of the First 2.5 Years’ Experience16
Prehospital Whole Blood Transfusion Programs in Norway15
Functional Testing for Tranexamic Acid Duration of Action Using Modified Viscoelastometry15
XK-Associated McLeod Syndrome: Nonhematological Manifestations and Relation to VPS13A Disease14
Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn13
Big Data in Transfusion Medicine and Artificial Intelligence Analysis for Red Blood Cell Quality Control13
Advanced Therapy Medicinal Products and the Changing Role of Academia12
Platelet-Rich Plasma in Plastic Surgery: A Systematic Review12
Emergency Blood Transfusion for Trauma and Perioperative Resuscitation: Standard of Care11
The Impact of COVID-19 on Blood Transfusion Services: A Systematic Review and Meta-Analysis11
Interferon Gamma Secretion of Adaptive and Innate Immune Cells as a Parameter to Describe Leukaemia-Derived Dendritic-Cell-Mediated Immune Responses in Acute Myeloid Leukaemia in vitro11
Relationship of SARS-CoV-2 Pandemic with Blood Groups10
Transfusion-Transmitted Malaria and Mitigation Strategies in Nonendemic Regions9
Monitoring of COVID-19-Associated Coagulopathy and Anticoagulation with Thromboelastometry9
Association of Blood Group Antigen CD59 with Disease9
Red Blood Cell Omics and Machine Learning in Transfusion Medicine: Singularity Is Near9
Effect of Methylene Blue Pathogen Inactivation on the Integrity of Immunoglobulin M and G8
Blood Donation-Related Adverse Reactions: Results of an Online Survey among Donors in Germany (2018)8
Improvement of Blood Processing and Safety by Automation and Pathogen Reduction Technology8
Predicting Successful Hematopoietic Stem Cell Collection in Healthy Allogeneic Donors7
High-Throughput Next-Generation Sequencing of the Kidd Blood Group: Unexpected Antigen Expression Properties of Four Alleles and Detection of Novel Variants7
Blood Product Supply for a Helicopter Emergency Medical Service7
Safety of Plasmapheresis in Donors with Low IgG Levels: Results of a Prospective, Controlled Multicentre Study6
Prehospital Plasma Transfusion: What Does the Literature Show?6
In the Mood for a Blood Donation? Pilot Study about Momentary Mood, Satisfaction, and Return Behavior in Deferred First-Time Donors6
Get Off on the Right Foot: How to Plan an Efficient Leukocytapheresis to Collect T Cells for CAR T-Cell Manufacturing6
Genotyping of Eight Human Platelet Antigen Systems in Serbian Blood Donors: Foundation for Platelet Apheresis Registry5
Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma5
Non-Invasive Fetal K Status Prediction: 7 Years of Experience5
Coagulation under Mild Hypothermia Assessed by Thromboelastometry5
Factors Associated with Intention to Donate Hematopoietic Stem Cells among Blood Donors5
Comparison of a New IgG-EIA for the Detection of Anti-Plasmodium Antibodies with Two Currently Used Assays5
Patient Blood Management in Pregnancy5
Population-Based Analysis of the Impact of Demographics on the Current and Future Blood Supply in the Saarland4
Urgent Need to Regulate Convalescent Plasma Differently from Thawed Plasma4
Severe Acute Hemolytic Transfusion Reaction Treated with Ruxolitinib and Plasma Exchange4
Monitoring Blood Supply in Germany: A Regulatory Perspective4
Detectable SARS-CoV-2 RNAemia in Critically Ill Patients, but Not in Mild and Asymptomatic Infections4
Comparison of Total Immunoglobulin G in Ante- and Postmortem Blood Samples from Tissue Donors4
A Para-Bombay Blood Group Case Associated with a Novel <b><i>FUT1</i></b> Mutation c.361G&#x3e;A4
Risk Factors and Outcomes of Stem Cell Mobilization Failure in Multiple Myeloma Patients4
Platelet-Rich Fibrin in Oral Surgery and Implantology: A Narrative Review4
Omics Technologies in Veterinary Medicine: Literature Review and Perspectives in Transfusion Medicine4
Prevalence of Occult Hepatitis B Virus Infection in Blood Donors with Negative ID-NAT in Switzerland4
10 Years of Experience with the First Thawed Plasma Bank in Germany4
Using the World Apheresis Association Registry Helps to Improve the Treatment Quality of Therapeutic Apheresis4
Noninferior Red Cell Concentrate Quality after Repeated Air Rescue Mission Transport for Prehospital Transfusion4
Augustine Blood Group System and Equilibrative Nucleoside Transporter 14
Application of Blood Group Genotyping by Next-Generation Sequencing in Various Immunohaematology Cases4
The Effect of Sex-Mismatched Red Blood Cell Transfusion on Endothelial Cell Activation in Critically Ill Patients4
Circulating Iron in Patients with Sickle Cell Disease Mediates the Release of Neutrophil Extracellular Traps3
Exome-Based Trio Analysis for Diagnosis of the Cause of Congenital Severe Hemolytic Anemia in a Child3
Effects of Different Hemoglobin Levels on Near-Infrared Spectroscopy-Derived Cerebral Oxygen Saturation in Elderly Patients Undergoing Noncardiac Surgery3
Regulatory Measures to Improve the Safety of CAR-T-Cell Treatment3
Variances in Antiviral Memory T-Cell Repertoire of CD45RA- and CD62L-Depleted Lymphocyte Products Reflect the Need of Individual T-Cell Selection Strategies to Reduce the Risk of GvHD while Preserving3
54. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI), 22.–24. September 2021, DIGITAL, Abstracts3
Validation of Microbiological Testing of Tissue Preparations with Different Incubation Temperatures3
Effect of Blood Groups on Clinical Presentations and Treatment Outcomes in Immune Thrombotic Thrombocytopenic Purpura Patients with Severe ADAMTS13 Deficiency: A Multi-Center Experience3
Blood Groups and Their Correlation with Hereditary Disease3
Analysis of Transfusion-Transmitted Bacterial Infections according to German Hemovigilance Data (2011–2020)3
Principles of Therapeutic Apheresis in Neurological Disease3
The Impact of Prepartum Platelet Count on Postpartum Blood Loss and Its Association with Coagulation Factor XIII Activity3
The Prognostic Value of TP53 Mutations in Adult Acute Myeloid Leukemia: A Meta-Analysis2
Ethical Issues and Management of Fetal Hemolytic Anemia Caused by Anti-Rh17 in a Multipara with Rare –D– Phenotype2
Algorithms for the Testing of Tissue Donors for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus2
Profiling and Bioinformatics Analysis Revealing Differential Circular RNA Expression about Storage Lesion Regulatory in Stored Red Blood Cells2
55. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie e. V. (DGTI), 21.–23. September 2022, Mannheim, ABSTRACTS2
Neutralizing Antibodies against SARS-CoV-2 and HLA Class I and II Polymorphism2
The Evolution of Blood Product Use in Trauma Resuscitation: Change Has Come2
Neonatal Immune Neutropenia due to Isoantibodies against the Granulocyte Receptor FcγRIIIb2
56. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie e. V. (DGTI), 20.–22. September 2023, Berlin, ABSTRACTS2
Efficacy and Safety of Blood Derivative Therapy for Patients with COVID-19: A Systematic Review and Meta-Analysis2
A Novel Mutation Eliminates GATA-1 and RUNX1-Mediated Promoter Activity in Galactosyltransferase Gene2
Factor XIII in the Acute Care Setting and Its Relevance in Obstetric Bleeding2
Predicting Individual Patient Platelet Demand in a Large Tertiary Care Hospital Using Machine Learning2
Successful Desensitization with Imlifidase and Daratumumab in a Highly Immunized, Crossmatch Positive, Blood Group-Incompatible Living-Donor Re-Transplant Recipient with Systemic Lupus Erythematosus a2
Occurrence of Rare Deletional Yus and Gerbich Alleles in Syria and Neighbouring Countries2
Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients2
Molecular Screening of Blood Donors for Babesia in Tyrol, Austria2
Undisclosed Sexual Risk Exposures: Results of a Nationwide Compliance Study among Whole Blood Donors in Germany2
P-Null Phenotype Due to a Rare Frame-Shift Mutation and with Allo-Anti-PP1Pk Causing a Severe Hemolytic Transfusion Reaction: A Case Report with Clinical Management2
Comment to Moog et al.: Safety of Plasmapheresis in Donors with Low IgG Levels: Results of a Prospective, Controlled Multicentre Study2
Completing the Donor History Questionnaire before the Donation Visit Can Improve Blood Safety2
Successful Management of Severe Hyperhaemolysis with Combined Tocilizumab and Rituximab in Non-Transfusion-Dependent Thalassaemia: A Case Report2
An Evaluation of Morphological Changes and Deformability of Suspended Red Blood Cells Prepared Using Whole Blood with Different Hemoglobin Levels of Tibetans2
Flow Cytometric Characterization of Hematopoietic Stem and Progenitor Cell Subpopulations in Autologous Peripheral Blood Stem Cell Preparations after Cryopreservation2
A Cross-Sectional Study of Blood Donors’ Psychological Characteristics over 8 Weeks2
Therapeutic Leukapheresis: Experience of a Single Oncologic Centre2
0.044030904769897